B G Koefoed1, P Petersen. Show Affiliations » 1. Danish National Board of Health, Copenhagen, Denmark.
Abstract
Entities: Disease
Mesh: See more » Aspirin/administration & dosageAspirin/adverse effectsAtrial Fibrillation/complicationsAtrial Fibrillation/drug therapyCerebrovascular Disorders/etiologyCerebrovascular Disorders/prevention & controlClinical Trials as TopicFibrinolytic Agents/administration & dosageFibrinolytic Agents/adverse effectsHumansWarfarin/administration & dosageWarfarin/adverse effects
Substances: See more » Fibrinolytic AgentsWarfarinAspirin
Year: 1999 PMID: 10337363 DOI: 10.1023/a:1008835505438
Source DB: PubMed Journal: J Thromb Thrombolysis ISSN: 0929-5305 Impact factor: 2.300